The Framingham facility alleges that labs who manipulate cannabis safety testing are enriching themselves at their expense.
The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.
Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback